Citigroup Inc Gelesis Holdings, Inc. Transaction History

Citigroup Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.22 - $0.51 $26 - $60	-119 Reduced 49.79%	120 $0
Q3 2022 Nov 10, 2022	SELL	$0.08 - $1.34 $29 - $490	-366 Reduced 60.5%	239 $0
Q2 2022 Aug 10, 2022	BUY	N/A	605 New	605 $1,000

4.7K

Ticker GLS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,946,704
Market Cap $1.46M
Description
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.